According to the research report, the global market for Terlipressin for Injection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Terlipressin for Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Terlipressin for Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Lumps segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Internal Medicine Application has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Terlipressin for Injection include Ferring Pharmaceuticals, Ranbaxy UK Ltd, TAJ LIFE SCIENCES, Mallinckrodt plc, EVER Pharma, Alliance Pharmaceuticals, Serum Institute of India Pvt. Ltd, Biovenice Criticure and Criticine Care, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Terlipressin for injection is a synthetic polypeptide that is an analog of the hormone secreted by the posterior pituitary gland. After injection, its triglycyl group will be cleaved by enzymes in the body to slowly release active substances such as vasopressin, which can contract smooth muscles and last for 10 hours. Vasopressin mainly has two effects: one is the obvious vasoconstriction effect, thereby reducing the venous blood flow to the hepatic portal system, thereby lowering the portal blood pressure and having a hemostatic effect; Body, prevent excessive loss of water in urine, has anti-enuresis function. Terlipressin for injection lowers HVPG faster, stronger, and longer, and it is a drug for the treatment of complications of portal hypertension.

This report aims to provide a comprehensive study of the global market for Terlipressin for Injection. Report Highlights:

(1) Global Terlipressin for Injection market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Terlipressin for Injection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Terlipressin for Injection market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Terlipressin for Injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Terlipressin for Injection segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Terlipressin for Injection, capacity, production and trends.

(7) Terlipressin for Injection industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Lumps

Powder

Market segment by application, can be divided into

Internal Medicine Application

surgical application

Intensive Care Unit (ICU) Applications

Market segment by players, this report covers

Ferring Pharmaceuticals

Ranbaxy UK Ltd

TAJ LIFE SCIENCES

Mallinckrodt plc

EVER Pharma

Alliance Pharmaceuticals

Serum Institute of India Pvt. Ltd

Biovenice Criticure

Criticine Care

Integrated Laboratories Pvt Ltd

Hybio Pharmaceutical Co., Ltd

Fujian Mindong Rejuenation Pharmaceutical Co., Ltd

Hangzhou Ausia Biological Technology Company, Ltd

Nanjing Kangzhou Pharmaceutical Technology Co., Ltd

Hainan General Sanyang Pharmaceutical Co., Ltd

1 Market Overview

1.1 Terlipressin for Injection Definition

1.2 Global Terlipressin for Injection Market Size and Forecast

1.2.1 By Revenue, Global Terlipressin for Injection Market Size, 2018-2029

1.2.2 By Sales Volume, Global Terlipressin for Injection Market Size, 2018-2029

1.2.3 Global Terlipressin for Injection Price Trend, 2018-2029

1.3 China Terlipressin for Injection Market Size and Forecast

1.3.1 By Revenue, China Terlipressin for Injection Market Size, 2018-2029

1.3.2 By Sales Volume, China Terlipressin for Injection Market Size, 2018-2029

1.3.3 China Terlipressin for Injection Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Terlipressin for Injection Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Terlipressin for Injection Share in Global Market, 2018-2029

1.4.3 Terlipressin for Injection Market Size: China VS Global, 2018-2029

1.5 Terlipressin for Injection Market Dynamics

1.5.1 Terlipressin for Injection Market Drivers

1.5.2 Terlipressin for Injection Market Restraints

1.5.3 Terlipressin for Injection Industry Trends

1.5.4 Terlipressin for Injection Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Terlipressin for Injection Revenue by Company, 2018-2023

2.2 Global Terlipressin for Injection Sales Volume by Company, 2018-2023

2.3 Global Terlipressin for Injection Price by Company, 2018-2023

2.4 Global Terlipressin for Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Terlipressin for Injection Concentration Ratio

2.6 Global Terlipressin for Injection Mergers & Acquisitions, Expansion Plans

2.7 Global Terlipressin for Injection Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Terlipressin for Injection Revenue by Company, 2018-2023

3.2 China Terlipressin for Injection Sales Volume by Company, 2018-2023

3.3 China Terlipressin for Injection Terlipressin for Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Terlipressin for Injection Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Terlipressin for Injection Domestic VS Export

3.6 China Market, Terlipressin for Injection Import & Export

3.6.1 China Market, Terlipressin for Injection Import & Export, 2018-2029

3.6.2 China Terlipressin for Injection Import & Export Trends

3.6.3 Main Sources of China Terlipressin for Injection Import

3.6.4 Export Destination of China Terlipressin for Injection

4 Terlipressin for Injection Production by Region

4.1 Global Terlipressin for Injection Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Terlipressin for Injection Manufacturers

4.3 Global Major Manufacturers, Terlipressin for Injection Capacity Expansion and Future Plans

4.4 Global Terlipressin for Injection Capacity by Region

4.5 Global Terlipressin for Injection Production by Region

4.5.1 Global Terlipressin for Injection Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Terlipressin for Injection Production by Region, 2018-2023

4.5.3 Global Terlipressin for Injection Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Terlipressin for Injection Industry Chain

5.2 Terlipressin for Injection Upstream Analysis

5.2.1 Terlipressin for Injection Core Raw Materials

5.2.2 Main Manufacturers of Terlipressin for Injection Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Terlipressin for Injection Production Mode

5.6 Terlipressin for Injection Procurement Model

5.7 Terlipressin for Injection Industry Sales Model and Sales Channels

5.7.1 Terlipressin for Injection Sales Model

5.7.2 Terlipressin for Injection Typical Distributors

6 Sights by Type

6.1 Terlipressin for Injection Classification

6.1.1 Lumps

6.1.2 Powder

6.2 By Type, Global Terlipressin for Injection Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Terlipressin for Injection Revenue, 2018-2029

6.4 By Type, Global Terlipressin for Injection Sales Volume, 2018-2029

6.5 By Type, Global Terlipressin for Injection Price, 2018-2029

7 Sights by Application

7.1 Terlipressin for Injection Segment by Application

7.1.1 Internal Medicine Application

7.1.2 surgical application

7.1.3 Intensive Care Unit (ICU) Applications

7.2 By Application, Global Terlipressin for Injection Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Terlipressin for Injection Revenue, 2018-2029

7.4 By Application, Global Terlipressin for Injection Sales Volume, 2018-2029

7.5 By Application, Global Terlipressin for Injection Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Terlipressin for Injection Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Terlipressin for Injection Revenue, 2018-2029

8.3 By Region, Global Terlipressin for Injection Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Terlipressin for Injection Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Terlipressin for Injection Market Size Market Share

8.5 Europe

8.5.1 Europe Terlipressin for Injection Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Terlipressin for Injection Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Terlipressin for Injection Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Terlipressin for Injection Market Size Market Share

8.7 South America

8.7.1 South America Terlipressin for Injection Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Terlipressin for Injection Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Terlipressin for Injection Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Terlipressin for Injection Revenue, 2018-2029

9.3 By Country, Global Terlipressin for Injection Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Terlipressin for Injection Market Size, 2018-2029

9.4.2 By Company, U.S. Terlipressin for Injection Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Terlipressin for Injection Market Size, 2018-2029

9.5.2 By Company, Europe Terlipressin for Injection Sales Volume Market Share, 2022

9.5.3 By Type, Europe Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Terlipressin for Injection Market Size, 2018-2029

9.6.2 By Company, China Terlipressin for Injection Sales Volume Market Share, 2022

9.6.3 By Type, China Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Terlipressin for Injection Market Size, 2018-2029

9.7.2 By Company, Japan Terlipressin for Injection Sales Volume Market Share, 2022

9.7.3 By Type, Japan Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Terlipressin for Injection Market Size, 2018-2029

9.8.2 By Company, South Korea Terlipressin for Injection Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Terlipressin for Injection Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Terlipressin for Injection Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Terlipressin for Injection Market Size, 2018-2029

9.10.2 By Company, India Terlipressin for Injection Sales Volume Market Share, 2022

9.10.3 By Type, India Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Terlipressin for Injection Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Terlipressin for Injection Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Terlipressin for Injection Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Terlipressin for Injection Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Ferring Pharmaceuticals

10.1.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.1.2 Ferring Pharmaceuticals Terlipressin for Injection Models, Specifications and Application

10.1.3 Ferring Pharmaceuticals Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Ferring Pharmaceuticals Company Profile and Main Business

10.1.5 Ferring Pharmaceuticals Recent Developments

10.2 Ranbaxy UK Ltd

10.2.1 Ranbaxy UK Ltd Company Information, Head Office, Market Area and Industry Position

10.2.2 Ranbaxy UK Ltd Terlipressin for Injection Models, Specifications and Application

10.2.3 Ranbaxy UK Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Ranbaxy UK Ltd Company Profile and Main Business

10.2.5 Ranbaxy UK Ltd Recent Developments

10.3 TAJ LIFE SCIENCES

10.3.1 TAJ LIFE SCIENCES Company Information, Head Office, Market Area and Industry Position

10.3.2 TAJ LIFE SCIENCES Terlipressin for Injection Models, Specifications and Application

10.3.3 TAJ LIFE SCIENCES Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 TAJ LIFE SCIENCES Company Profile and Main Business

10.3.5 TAJ LIFE SCIENCES Recent Developments

10.4 Mallinckrodt plc

10.4.1 Mallinckrodt plc Company Information, Head Office, Market Area and Industry Position

10.4.2 Mallinckrodt plc Terlipressin for Injection Models, Specifications and Application

10.4.3 Mallinckrodt plc Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Mallinckrodt plc Company Profile and Main Business

10.4.5 Mallinckrodt plc Recent Developments

10.5 EVER Pharma

10.5.1 EVER Pharma Company Information, Head Office, Market Area and Industry Position

10.5.2 EVER Pharma Terlipressin for Injection Models, Specifications and Application

10.5.3 EVER Pharma Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 EVER Pharma Company Profile and Main Business

10.5.5 EVER Pharma Recent Developments

10.6 Alliance Pharmaceuticals

10.6.1 Alliance Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.6.2 Alliance Pharmaceuticals Terlipressin for Injection Models, Specifications and Application

10.6.3 Alliance Pharmaceuticals Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Alliance Pharmaceuticals Company Profile and Main Business

10.6.5 Alliance Pharmaceuticals Recent Developments

10.7 Serum Institute of India Pvt. Ltd

10.7.1 Serum Institute of India Pvt. Ltd Company Information, Head Office, Market Area and Industry Position

10.7.2 Serum Institute of India Pvt. Ltd Terlipressin for Injection Models, Specifications and Application

10.7.3 Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Serum Institute of India Pvt. Ltd Company Profile and Main Business

10.7.5 Serum Institute of India Pvt. Ltd Recent Developments

10.8 Biovenice Criticure

10.8.1 Biovenice Criticure Company Information, Head Office, Market Area and Industry Position

10.8.2 Biovenice Criticure Terlipressin for Injection Models, Specifications and Application

10.8.3 Biovenice Criticure Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Biovenice Criticure Company Profile and Main Business

10.8.5 Biovenice Criticure Recent Developments

10.9 Criticine Care

10.9.1 Criticine Care Company Information, Head Office, Market Area and Industry Position

10.9.2 Criticine Care Terlipressin for Injection Models, Specifications and Application

10.9.3 Criticine Care Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Criticine Care Company Profile and Main Business

10.9.5 Criticine Care Recent Developments

10.10 Integrated Laboratories Pvt Ltd

10.10.1 Integrated Laboratories Pvt Ltd Company Information, Head Office, Market Area and Industry Position

10.10.2 Integrated Laboratories Pvt Ltd Terlipressin for Injection Models, Specifications and Application

10.10.3 Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Integrated Laboratories Pvt Ltd Company Profile and Main Business

10.10.5 Integrated Laboratories Pvt Ltd Recent Developments

10.11 Hybio Pharmaceutical Co., Ltd

10.11.1 Hybio Pharmaceutical Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.11.2 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications and Application

10.11.3 Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Hybio Pharmaceutical Co., Ltd Company Profile and Main Business

10.11.5 Hybio Pharmaceutical Co., Ltd Recent Developments

10.12 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd

10.12.1 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.12.2 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications and Application

10.12.3 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Profile and Main Business

10.12.5 Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments

10.13 Hangzhou Ausia Biological Technology Company, Ltd

10.13.1 Hangzhou Ausia Biological Technology Company, Ltd Company Information, Head Office, Market Area and Industry Position

10.13.2 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Models, Specifications and Application

10.13.3 Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Hangzhou Ausia Biological Technology Company, Ltd Company Profile and Main Business

10.13.5 Hangzhou Ausia Biological Technology Company, Ltd Recent Developments

10.14 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd

10.14.1 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.14.2 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Models, Specifications and Application

10.14.3 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Profile and Main Business

10.14.5 Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments

10.15 Hainan General Sanyang Pharmaceutical Co., Ltd

10.15.1 Hainan General Sanyang Pharmaceutical Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.15.2 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications and Application

10.15.3 Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Hainan General Sanyang Pharmaceutical Co., Ltd Company Profile and Main Business

10.15.5 Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Terlipressin for Injection Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Terlipressin for Injection Market Restraints

Table 3. Terlipressin for Injection Market Trends

Table 4. Terlipressin for Injection Industry Policy

Table 5. Global Terlipressin for Injection Revenue by Company, 2018-2023, US$ million

Table 6. Global Terlipressin for Injection Revenue Market Share by Company, 2018-2023

Table 7. Global Terlipressin for Injection Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Terlipressin for Injection Sales Volume Market Share by Company, 2018-2023

Table 9. Global Terlipressin for Injection Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Terlipressin for Injection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Terlipressin for Injection Mergers & Acquisitions, Expansion Plans

Table 12. Global Terlipressin for Injection Manufacturers Product Type

Table 13. China Terlipressin for Injection Revenue by Company, 2018-2023, US$ million

Table 14. China Terlipressin for Injection Revenue Market Share by Company, 2018-2023

Table 15. China Terlipressin for Injection Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Terlipressin for Injection Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Terlipressin for Injection Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Terlipressin for Injection Import & Export Trends

Table 19. Main Sources of China Terlipressin for Injection Import

Table 20. Export Destination of China Terlipressin for Injection

Table 21. Global Headquarters and Manufacturing Base of Terlipressin for Injection Manufacturers

Table 22. Global Major Manufacturers, Terlipressin for Injection Capacity Expansion and Future Plans

Table 23. Global Terlipressin for Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Terlipressin for Injection Production by Region, 2018-2023, (K Units)

Table 25. Global Terlipressin for Injection Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Terlipressin for Injection Upstream (Raw Materials)

Table 27. Global Terlipressin for Injection Typical Customers

Table 28. Terlipressin for Injection Typical Distributors

Table 29. By Type, Global Terlipressin for Injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Terlipressin for Injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Terlipressin for Injection Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Terlipressin for Injection Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Terlipressin for Injection Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Terlipressin for Injection Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Terlipressin for Injection Revenue Market Share, 2018-2029

Table 37. By Country, Global Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Terlipressin for Injection Sales Volume Market Share, 2018-2029

Table 39. Ferring Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 40. Ferring Pharmaceuticals Terlipressin for Injection Models, Specifications and Application

Table 41. Ferring Pharmaceuticals Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Ferring Pharmaceuticals Company Profile and Main Business

Table 43. Ferring Pharmaceuticals Recent Developments

Table 44. Ranbaxy UK Ltd Company Information, Head Office, Market Area and Industry Position

Table 45. Ranbaxy UK Ltd Terlipressin for Injection Models, Specifications and Application

Table 46. Ranbaxy UK Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Ranbaxy UK Ltd Company Profile and Main Business

Table 48. Ranbaxy UK Ltd Recent Developments

Table 49. TAJ LIFE SCIENCES Company Information, Head Office, Market Area and Industry Position

Table 50. TAJ LIFE SCIENCES Terlipressin for Injection Models, Specifications and Application

Table 51. TAJ LIFE SCIENCES Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. TAJ LIFE SCIENCES Company Profile and Main Business

Table 53. TAJ LIFE SCIENCES Recent Developments

Table 54. Mallinckrodt plc Company Information, Head Office, Market Area and Industry Position

Table 55. Mallinckrodt plc Terlipressin for Injection Models, Specifications and Application

Table 56. Mallinckrodt plc Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Mallinckrodt plc Company Profile and Main Business

Table 58. Mallinckrodt plc Recent Developments

Table 59. EVER Pharma Company Information, Head Office, Market Area and Industry Position

Table 60. EVER Pharma Terlipressin for Injection Models, Specifications and Application

Table 61. EVER Pharma Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. EVER Pharma Company Profile and Main Business

Table 63. EVER Pharma Recent Developments

Table 64. Alliance Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 65. Alliance Pharmaceuticals Terlipressin for Injection Models, Specifications and Application

Table 66. Alliance Pharmaceuticals Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Alliance Pharmaceuticals Company Profile and Main Business

Table 68. Alliance Pharmaceuticals Recent Developments

Table 69. Serum Institute of India Pvt. Ltd Company Information, Head Office, Market Area and Industry Position

Table 70. Serum Institute of India Pvt. Ltd Terlipressin for Injection Models, Specifications and Application

Table 71. Serum Institute of India Pvt. Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Serum Institute of India Pvt. Ltd Company Profile and Main Business

Table 73. Serum Institute of India Pvt. Ltd Recent Developments

Table 74. Biovenice Criticure Company Information, Head Office, Market Area and Industry Position

Table 75. Biovenice Criticure Terlipressin for Injection Models, Specifications and Application

Table 76. Biovenice Criticure Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Biovenice Criticure Company Profile and Main Business

Table 78. Biovenice Criticure Recent Developments

Table 79. Criticine Care Company Information, Head Office, Market Area and Industry Position

Table 80. Criticine Care Terlipressin for Injection Models, Specifications and Application

Table 81. Criticine Care Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Criticine Care Company Profile and Main Business

Table 83. Criticine Care Recent Developments

Table 84. Integrated Laboratories Pvt Ltd Company Information, Head Office, Market Area and Industry Position

Table 85. Integrated Laboratories Pvt Ltd Terlipressin for Injection Models, Specifications and Application

Table 86. Integrated Laboratories Pvt Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Integrated Laboratories Pvt Ltd Company Profile and Main Business

Table 88. Integrated Laboratories Pvt Ltd Recent Developments

Table 89. Hybio Pharmaceutical Co., Ltd Company Information, Head Office, Market Area and Industry Position

Table 90. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications and Application

Table 91. Hybio Pharmaceutical Co., Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Hybio Pharmaceutical Co., Ltd Company Profile and Main Business

Table 93. Hybio Pharmaceutical Co., Ltd Recent Developments

Table 94. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Information, Head Office, Market Area and Industry Position

Table 95. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications and Application

Table 96. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Company Profile and Main Business

Table 98. Fujian Mindong Rejuenation Pharmaceutical Co., Ltd Recent Developments

Table 99. Hangzhou Ausia Biological Technology Company, Ltd Company Information, Head Office, Market Area and Industry Position

Table 100. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Models, Specifications and Application

Table 101. Hangzhou Ausia Biological Technology Company, Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Hangzhou Ausia Biological Technology Company, Ltd Company Profile and Main Business

Table 103. Hangzhou Ausia Biological Technology Company, Ltd Recent Developments

Table 104. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Information, Head Office, Market Area and Industry Position

Table 105. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Models, Specifications and Application

Table 106. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Company Profile and Main Business

Table 108. Nanjing Kangzhou Pharmaceutical Technology Co., Ltd Recent Developments

Table 109. Hainan General Sanyang Pharmaceutical Co., Ltd Company Information, Head Office, Market Area and Industry Position

Table 110. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Models, Specifications and Application

Table 111. Hainan General Sanyang Pharmaceutical Co., Ltd Terlipressin for Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Hainan General Sanyang Pharmaceutical Co., Ltd Company Profile and Main Business

Table 113. Hainan General Sanyang Pharmaceutical Co., Ltd Recent Developments

List of Figure

Figure 1. Terlipressin for Injection Picture

Figure 2. By Revenue, Global Terlipressin for Injection Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Terlipressin for Injection Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Terlipressin for Injection Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Terlipressin for Injection Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Terlipressin for Injection Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Terlipressin for Injection Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Terlipressin for Injection Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Terlipressin for Injection Share of Global Market, 2018-2029

Figure 10. Global Terlipressin for Injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Terlipressin for Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Terlipressin for Injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Terlipressin for Injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Terlipressin for Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Terlipressin for Injection Domestic VS Export, 2022

Figure 16. Global Terlipressin for Injection Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Terlipressin for Injection Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Terlipressin for Injection Production Market Share & Forecast by Region, 2018-2029

Figure 19. Terlipressin for Injection Industry Chain

Figure 20. Terlipressin for Injection Procurement Model

Figure 21. Terlipressin for Injection Sales Model

Figure 22. Terlipressin for Injection Sales Channels, Direct Sales and Distribution

Figure 23. Lumps

Figure 24. Powder

Figure 25. By Type, Global Terlipressin for Injection Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Terlipressin for Injection Revenue Market Share, 2018-2029

Figure 27. By Type, Global Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Terlipressin for Injection Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Terlipressin for Injection Price, 2018-2029, (US$/Unit)

Figure 30. Internal Medicine Application

Figure 31. surgical application

Figure 32. Intensive Care Unit (ICU) Applications

Figure 33. By Application, Global Terlipressin for Injection Revenue, 2018-2029, US$ Million

Figure 34. By Application, Global Terlipressin for Injection Revenue Market Share, 2018-2029

Figure 35. By Application, Global Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 36. By Application, Global Terlipressin for Injection Sales Volume Market Share, 2018-2029

Figure 37. By Application, Global Terlipressin for Injection Price, 2018-2029, (US$/Unit)

Figure 38. By Region, Global Terlipressin for Injection Revenue Market Share, 2018-2029

Figure 39. By Region, Global Terlipressin for Injection Sales Volume Market Share, 2018-2029

Figure 40. North America Terlipressin for Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, North America Terlipressin for Injection Revenue Market Share, 2022

Figure 42. Europe Terlipressin for Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, Europe Terlipressin for Injection Revenue Market Share, 2022

Figure 44. Asia Pacific Terlipressin for Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country/Region, Asia Pacific Terlipressin for Injection Revenue Market Share, 2022

Figure 46. South America Terlipressin for Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, South America Terlipressin for Injection Revenue Market Share, 2022

Figure 48. Middle East & Africa Terlipressin for Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. U.S. Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 50. By Company, U.S. Terlipressin for Injection Market Share, 2022

Figure 51. By Type, U.S. Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 54. By Company, Europe Terlipressin for Injection Market Share, 2022

Figure 55. By Type, Europe Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 57. China Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 58. By Company, China Terlipressin for Injection Market Share, 2022

Figure 59. By Type, China Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 62. By Company, Japan Terlipressin for Injection Market Share, 2022

Figure 63. By Type, Japan Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 66. By Company, South Korea Terlipressin for Injection Market Share, 2022

Figure 67. By Type, South Korea Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 70. By Company, Southeast Asia Terlipressin for Injection Market Share, 2022

Figure 71. By Type, Southeast Asia Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 73. India Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 74. By Company, India Terlipressin for Injection Market Share, 2022

Figure 75. By Type, India Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Terlipressin for Injection Sales Volume, 2018-2029, (K Units)

Figure 78. By Company, Middle East & Asia Terlipressin for Injection Market Share, 2022

Figure 79. By Type, Middle East & Asia Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, Middle East & Asia Terlipressin for Injection Sales Volume Market Share, 2022 VS 2029

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)